Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.

摘要: The price of prescription drugs lies at the heart two major public health issues: distributing antiretroviral medicines for use against global AIDS epidemic and purchasing medications from Canada by U.S. consumers using Internet. Both situations highlight need to reduce financial barriers access medications, while maintaining incentives promote pharmaceutical innovation. For better or worse, World Trade Organization’s (WTO) Agreement on Trade-Related Aspects Intellectual Property Rights (TRIPS) is a nexus drug issues. In TRIPS-related